相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma
Birte Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Linking Serine/Glycine Metabolism to Radiotherapy Resistance
Anais Sanchez-Castillo et al.
CANCERS (2021)
Metabolomics study reveals the potential evidence of metabolic reprogramming towards the Warburg effect in precancerous lesions
Xun Chen et al.
JOURNAL OF CANCER (2021)
Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy
Renee C. Geck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Glycine metabolomic changes induced by anticancer agents in A549 cells
Kaiqiang Guo et al.
AMINO ACIDS (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation
Hirofumi Yoshino et al.
MOLECULAR ONCOLOGY (2020)
Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress
Wangjie Yu et al.
CANCERS (2020)
Triple Negative Breast Cancer and Breast Epithelial Cells Differentially Reprogram Glucose and Lipid Metabolism upon Treatment with Triterpenic Acids
Angela R. Guerra et al.
BIOMOLECULES (2020)
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen et al.
METABOLITES (2020)
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
Venugopal Gunda et al.
CANCERS (2020)
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis
Xin You et al.
CANCER COMMUNICATIONS (2019)
Integration of Metabolomics and Transcriptomics To Reveal Metabolic Characteristics and Key Targets Associated with Cisplatin Resistance in Nonsmall Cell Lung Cancer
Yuhuan Shi et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Multi-Organ NMR Metabolomics to Assess In Vivo Overall Metabolic Impact of Cisplatin in Mice
Tatiana J. Carneiro et al.
METABOLITES (2019)
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Su Ji Kim et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data
Jasmine Chong et al.
BIOINFORMATICS (2018)
Metabolic vulnerability of cisplatin-resistant cancers
Florine Obrist et al.
EMBO JOURNAL (2018)
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong et al.
NUCLEIC ACIDS RESEARCH (2018)
Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
Min Young Lee et al.
Oncotarget (2018)
High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer
Nathan C. W. Lee et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1H HR-MAS NMR spectroscopy
Roberta M. Maria et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
Won-Jun Jang et al.
ONCOTARGET (2017)
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
Medhi Wangpaichitr et al.
ONCOTARGET (2017)
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
Sajad Dar et al.
SCIENTIFIC REPORTS (2017)
Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer
Hongde Li et al.
CELL DISCOVERY (2016)
A metabolomic approach to identifying platinum resistance in ovarian cancer
Laila M. Poisson et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
Bei Cao et al.
METABOLOMICS (2013)
Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil
Shinsuke Sasada et al.
ONCOLOGY REPORTS (2013)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Metabolic Reprogramming in Ovarian Cancer Cells Resistant to Cisplatin
M. Montopoli et al.
CURRENT CANCER DRUG TARGETS (2011)
Decision tree supported substructure prediction of metabolites from GC-MS profiles
Jan Hummel et al.
METABOLOMICS (2010)
分享论文
